Medicare Characteristic | Spending Component | |||||
---|---|---|---|---|---|---|
Low | High | |||||
Average Beta Coefficient | Average Standard Error | 95% CI Standard Error | Average Beta Coefficient | Average Standard Error | 95% CI Standard Error | |
Intercept | 7.480 | 0.069 | [7.345, 7.615] | 7.396 | 0.310 | [6.789, 8.004] |
Time to Sitagliptin Adoptiona | 0.001 | 0.003 | [− 0.005, 0.006] | − 0.003 | 0.006 | [− 0.016, 0.010] |
% Adopting Sitagliptina | 0.345 | 0.072 | [0.203, 0.487] | 0.148 | 0.258 | [−0.359, 0.654] |
Age | − 0.002 | 0.000 | [− 0.003, − 0.001] | 0.001 | 0.001 | [− 0.001, 0.003] |
Female | − 0.033 | 0.011 | [− 0.054, − 0.012] | −0.015 | 0.015 | [−0.044, 0.013] |
Race (Ref = White) | ||||||
 Black | −0.272 | 0.027 | [−0.325, − 0.218] | −0.443 | 0.017 | [−0.475, − 0.410] |
 Hispanic | −0.218 | 0.030 | [−0.277, − 0.160] | −0.257 | 0.033 | [−0.321, − 0.192] |
 Race other | −0.072 | 0.039 | [−0.149, 0.004] | 0.018 | 0.036 | [−0.052, 0.088] |
Eligibility | ||||||
 Dual Eligible | −0.006 | 0.022 | [−0.048, 0.037] | − 0.029 | 0.028 | [− 0.084, 0.027] |
 Low Income Subsidy | 0.202 | 0.021 | [0.161, 0.243] | 0.305 | 0.025 | [0.255, 0.354] |
 Disabled | −0.146 | 0.018 | [−0.182, − 0.110] | −0.113 | 0.018 | [−0.148, − 0.077] |
Drug Type (Ref = Combo) | ||||||
 Oral only | −2.252 | 0.013 | [−2.278, −2.226] | −2.108 | 0.017 | [−2.142, − 2.074] |
 Injection only | − 0.178 | 0.017 | [− 0.211, − 0.145] | −0.260 | 0.023 | [−0.305, − 0.216] |
 Elixhauser | −0.012 | 0.002 | [−0.016, − 0.008] | −0.007 | 0.003 | [−0.012, − 0.002] |